Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel H Hovelson

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Endocrine-Related Cancer|November 27, 2018
Somatic mutations in adrenocortical carcinoma with primary aldosteronism or hyperreninemic hyperaldosteronismIsobel C Mouat, Kei Omata, Andrew S McDaniel, et al.
Neoplasia (New York, N.Y.)|July 6, 2019
Circulating Tumor Cell-Based Molecular Classifier for Predicting Resistance to Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate CancerJae-Seung Chung, Yugang Wang, James Henderson, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2015
Aldosterone-stimulating somatic gene mutations are common in normal adrenal glandsKoshiro Nishimoto, Scott A Tomlins, Rork Kuick, et al.
Human Pathology|April 13, 2016
Porocarcinomas harbor recurrent HRAS-activating mutations and tumor suppressor inactivating mutationsPaul W Harms, Daniel H Hovelson, Andi K Cani, et al.
Molecular Cancer Research : MCR|January 6, 2019
Multiclonality and Marked Branched Evolution of Low-Grade Endometrioid Endometrial CarcinomaLorena Lazo de la Vega, Mia C Samaha, Kevin Hu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 9, 2016
Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivationPaul W Harms, Angela M B Collie, Daniel H Hovelson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 23, 2016
Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapiesAndi K Cani, Moaaz Soliman, Daniel H Hovelson, et al.
Head & Neck|February 6, 2016
Fibroblast growth factor family aberrations as a putative driver of head and neck squamous cell carcinoma in an epidemiologically low-risk patient as defined by targeted sequencingBrittny N Tillman, Megan Yanik, Andrew C Birkeland, et al.
The Journal of Molecular Diagnostics : JMD|August 28, 2021
Development and Validation of StrataNGS, a Multiplex PCR, Semiconductor Sequencing-Based Comprehensive Genomic Profiling TestScott A Tomlins, Daniel H Hovelson, Paul Harms, et al.
Pharmacogenetics and Genomics|December 17, 2016
Characterization of ADME gene variation in 21 populations by exome sequencingDaniel H Hovelson, Zhengyu Xue, Matthew Zawistowski, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Endocrine-Related Cancer|November 27, 2018
Somatic mutations in adrenocortical carcinoma with primary aldosteronism or hyperreninemic hyperaldosteronismIsobel C Mouat, Kei Omata, Andrew S McDaniel, et al.
Neoplasia (New York, N.Y.)|July 6, 2019
Circulating Tumor Cell-Based Molecular Classifier for Predicting Resistance to Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate CancerJae-Seung Chung, Yugang Wang, James Henderson, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2015
Aldosterone-stimulating somatic gene mutations are common in normal adrenal glandsKoshiro Nishimoto, Scott A Tomlins, Rork Kuick, et al.
Human Pathology|April 13, 2016
Porocarcinomas harbor recurrent HRAS-activating mutations and tumor suppressor inactivating mutationsPaul W Harms, Daniel H Hovelson, Andi K Cani, et al.
Molecular Cancer Research : MCR|January 6, 2019
Multiclonality and Marked Branched Evolution of Low-Grade Endometrioid Endometrial CarcinomaLorena Lazo de la Vega, Mia C Samaha, Kevin Hu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 9, 2016
Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivationPaul W Harms, Angela M B Collie, Daniel H Hovelson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 23, 2016
Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapiesAndi K Cani, Moaaz Soliman, Daniel H Hovelson, et al.
Head & Neck|February 6, 2016
Fibroblast growth factor family aberrations as a putative driver of head and neck squamous cell carcinoma in an epidemiologically low-risk patient as defined by targeted sequencingBrittny N Tillman, Megan Yanik, Andrew C Birkeland, et al.
The Journal of Molecular Diagnostics : JMD|August 28, 2021
Development and Validation of StrataNGS, a Multiplex PCR, Semiconductor Sequencing-Based Comprehensive Genomic Profiling TestScott A Tomlins, Daniel H Hovelson, Paul Harms, et al.
Pharmacogenetics and Genomics|December 17, 2016
Characterization of ADME gene variation in 21 populations by exome sequencingDaniel H Hovelson, Zhengyu Xue, Matthew Zawistowski, et al.
Pageof 5